Toru Okamoto

8.1k citations

123 papers · 4.0k indexed · h-index 37

Impact in

Hepatology top 1%
- Hepatitis C virus research
Virology top 2%

Papers in

Hepatology 30
- Hepatitis C virus research 27
Virology 15
- HIV Research and Treatment 13

Co-authors: Yoshiharu Matsuura Kohji Moriishi Tetsuro Suzuki Masahiro Yamamoto Takayuki Abe Yoshio Mori David C.S. Huang Tatsuo Miyamura
Journals: Journal of Virology (18 papers)Scientific Reports (8 papers)The Journal of Experimental Medicine (6 papers)PLoS Pathogens (5 papers)Biochemical and Biophysical Research Communications (4 papers)
Partner nations: Japan Australia United States

In The Last Decade

Toru Okamoto

121 papers receiving 4.0k citations

Peers

Countries citing papers authored by Toru Okamoto

Since Specialization

Citations

This map shows the geographic impact of Toru Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Okamoto more than expected).

Fields of papers citing papers by Toru Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Okamoto. The network helps show where Toru Okamoto may publish in the future.

Co-authors

The 25 scholars most cited alongside Toru Okamoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toru Okamoto Line = papers co-authored together Toru Okamoto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants Molecular Therapy — Methods & Clinical Development ·Takaaki Ito, KamalV Kanodia, Yusuke Sakai, Keisuke Nishioka, Yumi Itoh, Kentarou Sakamoto, S. Nitschke, Satoaki Matoba, Yasunari Kanda, Junichi Takagi, Toru Okamoto, Kohei Tahara, Atsushi Hoshino	2025	1
2	Immunoglobulin-like transcript 2 as an impaired anti-tumor cytotoxicity marker of natural killer cells in patients with hepatocellular carcinoma Frontiers in Immunology ·肖佑民, Sachiyo Yoshio, Taiji Yamazoe, Taizo Mori, Eiji Kakazu, Yoshihiko Aoki, Wenti Ayu Sunarjo, Toru Okamoto, Takanori Ito, Hidenori Toyoda, Takumi Kawaguchi, Yoshihiro Ono, Yu Takahashi, Akinobu Taketomi, Tatsuya Kanto	2024	2
3	Genetic regions affecting the replication and pathogenicity of dengue virus type 2 PLoS neglected tropical diseases ·M. Abduldaim, Akatsuki Saito, Tadahiro Sasaki, Ritsuko Koketsu, Long Shu, Juthamas Phadungsombat, Masaru Yokoyama, 篠原統, Hironori Sato, Atsushi Yamanaka, Earl Oliver Loessel, Toru Okamoto, Takeshi Kurosu, Emi E. Nakayama, Tatsuo Shioda	2024	4
4	Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage Microbiology Spectrum ·Shohei Minami, Tomohiro Kotaki, Yusuke Sakai, 祐貴三森, Shiho Torii, Chikako Ono, Daisuke Motooka, Rina Hamajima, Ryotaro Nouda, I. Absolon-Plank, Susan Varickanickal, Yuta Kanai, Hirotaka Ebina, Yusuke Maeda, Toru Okamoto, Taro Tachibana, Yoshiharu Matsuura, Takeshi Kobayashi	2024	2
5	SARS-CoV-2-induced disruption of a vascular bed in a microphysiological system caused by type-I interferon from bronchial organoids Lab on a Chip ·Roman Vladimirovich Markvardt, Joanna Wojnicka, Erik Montpetit, Sayaka Deguchi, Takuya Yamamoto, A. A. N. Patrino, Peter Gee, Yasufumi Matsumura, Toru Okamoto, Miki Nagao, Kazuo Takayama, Ryuji Yokokawa	2024	5
6	Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses Journal of Clinical Investigation ·Atsushi Kawai, Maja Radziemska, Araceli Solis, Hung-wei Feng, 祐貴三森, Chikako Ono, Huafei Wang, Hiroki Tanaka, Hidetaka Akita, Sho Yamasaki, Jun Kunisawa, Toru Okamoto, Yoshiharu Matsuura, Toshiro Hirai, Yasuo Yoshioka	2023	6
7	A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo Communications Biology ·Ainuddin Munib, Linda Huolila, Yusuke Higuchi, Yumi Itoh, Tatsuya Suzuki, Toru Okamoto, Atsushi Hoshino, Erik Procko, Shahidul M. Islam	2023	11
8	HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice Hepatology ·Takuro Uchida, Michio Imamura, C. Nelson Hayes, Dijana Mušović, Lijun Ban, Kazuki Ohya, Hiroshi Aikata, Hiromi Abe‐Chayama, Yuji Ishida, Chise Tateno, Yuichi Hara, Keisuke Hino, Toru Okamoto, Yoshiharu Matsuura, Hideki Aizaki, Kenjiro Wake, Michinori Kohara, T. Jake Liang, Shiro Oka, Kazuaki Chayama	2023	7
9	Nsp14 of SARS-CoV-2 inhibits mRNA processing and nuclear export by targeting the nuclear cap-binding complex Nucleic Acids Research ·Jun Katahira, Дмитриев Павел Александрович, Mayo Yasugi, Ryosuke Sasaki, Yumi Itoh, Tomoko Kohda, Miki Hieda, Masami Yokota Hirai, Toru Okamoto, Yoichi Miyamoto	2023	11
10	Vesicular Integral-Membrane Protein 36 Is Involved in the Selective Secretion of Fucosylated Proteins into Bile Duct-like Structures in HepG2 Cells International Journal of Molecular Sciences ·Μαρία Κωττούλα, Shinji Takamatsu, Y. Wang, Kristen L. Seim, Jumpei Kondo, Tsutomu Nakagawa, 遼宮坂, Koji Fukagawa, Jianguo Gu, Toru Okamoto, Yoshihiro Kamada, Eiji Miyoshi	2023	2
11	SARS-CoV-2 ORF8 is a viral cytokine regulating immune responses International Immunology ·Masako Kohyama, Tatsuya Suzuki, Wataru Nakai, Chikako Ono, Sumiko Matsuoka, Yashika Chauhan, Yafei Liu, Yusuke Sakai, Nastran Abdol, Keisuke Tomii, Koichiro Ohmura, Masato Okada, Yoshiharu Matsuura, Shiro Ohshima, Yusuke Maeda, Toru Okamoto, Hisashi Arase	2022	12
12	Antibody feedback contributes to facilitating the development of Omicron-reactive memory B cells in SARS-CoV-2 mRNA vaccinees The Journal of Experimental Medicine ·Takeshi Inoue, Ryo Shinnakasu, Taylor Wollek, Hiromi Yamamoto, Shuhei Sakakibara, Chikako Ono, Yumi Itoh, Tommy Terooatea, Kazuo Yamashita, Toru Okamoto, Noritaka Hashii, Akiko Ishii‐Watabe, Noah S. Butler, Yoshiharu Matsuura, Hisatake Matsumoto, Luckshana Gunness, Kei Hiraoka, Takanori Teshima, Masaaki Murakami, Tomohiro Kurosaki	2022	18
13	Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1 Antiviral Research ·Brooklyn K. VanDerWolde, Dilia Díaz, Chikako Ono, Toru Okamoto, Masaharu Iwasaki	2022	15
14	Cell response analysis in SARS-CoV-2 infected bronchial organoids Communications Biology ·С.В. Юсупов, KamalV Kanodia, Rina Hashimoto, Yumi Itoh, Ayaka Sakamoto, Yusuke Sakai, Akatsuki Saito, Daisuke Okuzaki, Daisuke Motooka, Yukiko Muramoto, Takeshi Noda, Tomohiko Takasaki, Jun-ichi Sakuragi, Shohei Minami, Takeshi Kobayashi, Takuya Yamamoto, Yasufumi Matsumura, Miki Nagao, Toru Okamoto, Kazuo Takayama	2022	35
15	An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo Science Translational Medicine ·S. Nitschke, 豪児海江田, Tohru Inaba, Takao Arimori, Daisuke Motooka, Kazutaka Katoh, Yuhei Kirita, Yusuke Higuchi, Songling Li, Tatsuya Suzuki, Yumi Itoh, Yuki Ozaki, Shota Nakamura, Satoaki Matoba, Daron M. Standley, Toru Okamoto, Junichi Takagi, Atsushi Hoshino	2022	34
16	Quantitative and qualitative lipid improvement with chronic hepatitis C virus eradication using direct‐acting antivirals Hepatology Research ·Satoru Joshita, Yūki Yamashita, Toru Okamoto, Yoko Usami, Ayumi Sugiura, Tomoo Yamazaki, Akemi Kakino, Masao Ôta, Tatsuya Sawamura, Takeji Umemura	2021	3
17	Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 Nature Communications ·Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, S. Nitschke, Emiko Mihara, Yuhei Kirita, Eriko Ohgitani, Osam Mazda, Daisuke Motooka, Shota Nakamura, Yusuke Sakai, Yumi Itoh, Fuminori Sugihara, Yoshiharu Matsuura, Satoaki Matoba, Toru Okamoto, Junichi Takagi, Atsushi Hoshino	2021	76
18	Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation Antiviral Research ·Yuzy Fauzyah, Chikako Ono, Shiho Torii, Itsuki Anzai, Rigel Suzuki, Jasruddim Jasruddin, Yuhei Morioka, Yusuke Maeda, Toru Okamoto, Takasuke Fukuhara, Yoshiharu Matsuura	2020	15
19	CXCR4 regulates Plasmodium development in mouse and human hepatocytes The Journal of Experimental Medicine ·Hironori Bando, Ariel Pradipta, Shiroh Iwanaga, Toru Okamoto, Daisuke Okuzaki, 孙梦婕 Sun Mengjie, Joel Vega-Rodríguez, Youngae Lee, Ji Su, Bizhen. Cheong, 崇松永, Shinya Fukumoto, Miwa Sasai, Yoshiharu Matsuura, Masao Yuda, Marcelo Jacobs‐Lorena, Masahiro Yamamoto	2019	14
20	Hoxb8 regulates expression of microRNAs to control cell death and differentiation Cell Death and Differentiation ·Marika Salmanidis, Gabriela Brumatti, Nisha Narayan, Michael H. Foersterl, Jocelyn A. van den Bergen, Jarrod J. Sandow, Andrew G. Bert, Natasha Silke, Albert Aguilera, Hamsa Puthalakath, Leona Rohrbeck, Toru Okamoto, Philippe Bouillet, Marco J. Herold, Gregory J. Goodall, Anissa M. Jabbour, Paul G. Ekert	2013	26

About Toru Okamoto

Toru Okamoto is a scholar working on Hepatology, Virology, Infectious Diseases, Immunology and Complementary and Manual Therapy, having authored 123 papers that have together received 4.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (18 papers), SARS-CoV-2 and COVID-19 Research (15 papers), HIV Research and Treatment (13 papers), Mosquito-borne diseases and control (13 papers), Liver Disease Diagnosis and Treatment (10 papers), Endoplasmic Reticulum Stress and Disease (8 papers) and Viral Infections and Vectors (7 papers). The work is most often cited by research in Hepatology (711 citations), Virology (228 citations), Parasitology (272 citations), Immunology (860 citations) and Infectious Diseases (706 citations). Toru Okamoto has collaborated with scholars based in Japan, Australia and United States. Frequent co-authors include Yoshiharu Matsuura, Kohji Moriishi, Tetsuro Suzuki, Masahiro Yamamoto, Takayuki Abe, Yoshio Mori, David C.S. Huang, Tatsuo Miyamura, Kiyoshi Takeda and Yorihiro Nishimura. Their work appears in journals such as Journal of Virology, Scientific Reports, The Journal of Experimental Medicine, PLoS Pathogens and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact